Non‐study post‐partum antibiotics use and risk of maternal and neonatal infection: A secondary analysis of the A‐ PLUS randomized controlled trial
International Journal of Gynecology & Obstetrics · 2026
DOI: 10.1002/ijgo.70721 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Gynecology & Obstetrics, 2026. Verfasst von Elizabeth M McClure und 34 weiteren Autor:innen. Beteiligte Einrichtung: Social, Statistical and Environmental Health Sciences, RTI International, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Azithromycin, Anti-Bacterial Agents, Neonatal Sepsis, Sepsis. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, National Institute of Child Health and Human Development and the Gates Foundation, Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Abstract (Originalsprache)
Objective
The randomized trial of azithromycin to reduce maternal and neonatal sepsis (the A‐PLUS Trial) found substantial reduction in maternal sepsis among women receiving azithromycin and substantial non‐study antibiotic use. This secondary analysis explored the effect modification of non‐study antibiotics on azithromycin versus placebo on maternal and newborn infection among A‐PLUS participants.
Methods
Women ≥28 weeks gestation in labor and planning a vaginal delivery at a study hospital in seven low‐ and middle‐income countries (Bangladesh, India [two sites], Pakistan, Guatemala, Kenya, Democratic Republic of Congo, and Zambia) were eligible for inclusion. Non‐study antibiotic use was collected prospectively. We estimated the interaction of non‐study antibiotics with azithromycin versus placebo on maternal and newborn sepsis.
Results
A total of 29 287 participants were randomized (14 590 to azithromycin; 14 688 to placebo). Maternal infection was reduced among the azithromycin group compared to placebo among those who did not receive non‐study antibiotics, with estimated relative risk (RR) 0.58 (95% confidence interval [CI] 0.48, 0.70), and among those who received non‐study antibiotics, with RR 0.80 (95% CI 0.70, 0.91). Similar results were observed for maternal sepsis. Neonatal infection was not significantly reduced in any group. These results were similar when stratified by African and Asian region but not statistically significant.
Conclusion
Our results suggest a benefit of azithromycin in reducing maternal infection or sepsis across all groups, with a larger reduction in risk among participants who had not received other antibiotics. Given the concerns of inappropriate use of antibiotics, further research is warranted to determine the most effective strategies of reducing risk of infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Social, Statistical and Environmental Health Sciences, RTI International, Durham, North Carolina, USA.
- School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Department of Community Health Sciences, Aga Khan University, Karachi, Pakistan.
- Department of Obstetrics and Gynecology, Mahatma Gandhi Institute of Medical Sciences, Sewagram, India.
- Department of Obstetrics and Gynecology, Government Medical College, Nagpur, India.
- Lata Medical Research Foundation, Nagpur, India.
ORCID-Profile: Elizabeth M McClure, Alan T N Tita, Waldemar A Carlo, Sarah Saleem, Shiyam Sunder Tikmani, Poonam Shivkumar, Avinash Kavi, Shivaprasad S Goudar, Adrien Lokangaka, Antoinette Tshefu, Fabian Esamai, Rashidul Haque, Sk Masum Billah, Richard J Derman, Melissa Bauserman, Carl L Bose, Patricia L Hibberd, Osayame Austine Ekhaguere, Sherri Bucher, William A Petri, Manolo Mazariegos, Nancy F Krebs, Edwin J Asturias, Marion Koso-Thomas, Robert L Goldenberg
Förderung
- NICHD NIH HHS
- National Institute of Child Health and Human Development and the Gates Foundation
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
Zitieren
APA
McClure, E. M., Tita, A. T. N., Carlo, W. A., Saleem, S., Moore, J. L., Jessani, S., Tikmani, S. S., Shivkumar, P., Waikar, M. R., Patel, A., Mwenechanya, M., Chomba, E., Kavi, A., Metgud, M. C., Goudar, S. S., Lokangaka, A., Tshefu, A., Nyongesa, P., Esamai, F., …, & Goldenberg, R. L. (2026). Non‐study post‐partum antibiotics use and risk of maternal and neonatal infection: A secondary analysis of the A‐ PLUS randomized controlled trial. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70721
Vancouver
McClure EM, Tita ATN, Carlo WA, Saleem S, Moore JL, Jessani S, et al. Non‐study post‐partum antibiotics use and risk of maternal and neonatal infection: A secondary analysis of the A‐ PLUS randomized controlled trial. International Journal of Gynecology & Obstetrics. 2026. doi:10.1002/ijgo.70721
BibTeX
@article{McClure2026,
author = {McClure, Elizabeth M and Tita, Alan T N and Carlo, Waldemar A and Saleem, Sarah and Moore, Janet L and Jessani, Saleem and Tikmani, Shiyam Sunder and Shivkumar, Poonam and Waikar, Manjushri R and Patel, Archana and Mwenechanya, Musaku and Chomba, Elwyn and Kavi, Avinash and Metgud, Mrityunjay C and Goudar, Shivaprasad S and Lokangaka, Adrien and Tshefu, Antoinette and Nyongesa, Paul and Esamai, Fabian and Haque, Rashidul and Billah, Sk Masum and Derman, Richard J and Bauserman, Melissa and Bose, Carl L and Hibberd, Patricia L and Ekhaguere, Osayame Austine and Bucher, Sherri and Petri, William A and Mazariegos, Manolo and Krebs, Nancy F and Asturias, Edwin J and Hemingway-Foday, Jennifer J and Babineau, Denise C and Koso-Thomas, Marion and Goldenberg, Robert L},
title = {Non‐study post‐partum antibiotics use and risk of maternal and neonatal infection: A secondary analysis of the A‐ PLUS randomized controlled trial},
journal = {International Journal of Gynecology & Obstetrics},
year = {2026},
doi = {10.1002/ijgo.70721}
}
EUVIMED